News | Point-of-Care Ultrasound (POCUS) | March 09, 2022

Fujifilm Sonosite Files Patent Infringement Lawsuit Against Butterfly Network

Fujifilm Sonosite, Inc., a world leader in point-of-care ultrasound (POCUS) solutions today announced it has filed a patent infringement lawsuit against Butterfly Network in the United States District Court for the District of Delaware.

March 9, 2022 — Fujifilm Sonosite, Inc., a world leader in point-of-care ultrasound (POCUS) solutions today announced it has filed a patent infringement lawsuit against Butterfly Network in the United States District Court for the District of Delaware.

Fujifilm has asserted seven patents (U.S. Patent Nos. 7,169,108; 7,867,168; 8,128,050; 8,861,822; 9,538,985; 6,901,157; and 8,360,981) pertaining to fundamental technologies for acquiring ultrasound images at the point of care with portable handheld systems. The patents cover various aspects of point of care ultrasound solutions, including the use of a probe coupled to a mobile device, elements of the graphical interface, as well as aspects related to the processing and display of ultrasound images.

Fujifilm Sonosite is seeking remedies including damages related to Butterfly Network's infringement through its unauthorized use, manufacture, marketing, promotion and sale of Butterfly Network's IQ/IQ+ POCUS products.

"Fujifilm Sonosite is committed to protecting its significant investments in resources and R&D, and in bringing novel technologies to clinicians for the ultimate benefit of improved patient care," said Rich Fabian, president and COO, Fujifilm Sonosite, Inc. "We will enforce and protect our intellectual property rights in the United States and around the world when we believe others infringe on it unfairly."

For more information: https://www.sonosite.com/


Related Content

News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
News | Cardiovascular Business

June 28, 2024 — After a year of dedicated service and outstanding leadership, Jodie L. Hurwitz, MD, FHRS, has now ended ...

Home June 28, 2024
Home
Subscribe Now